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Abstract
To complete cell division with high fidelity, cytokinesis must be coordinated with chromosome segregation. Mammalian
Polo-like kinase 1, Plk1, may function as a critical link because it is required for chromosome segregation and establishment
of the cleavage plane following anaphase onset. A central spindle–localized pool of the RhoGEF Ect2 promotes activation of
the small GTPase RhoA, which drives contractile ring assembly at the equatorial cortex. Here, we have investigated how Plk1
promotes the central spindle recruitment of Ect2. Plk1 phosphorylates the noncatalytic N terminus of the RhoGAP HsCyk-4
at the central spindle, creating a phospho-epitope recognized by the BRCA1 C-terminal (BRCT) repeats of Ect2. Failure to
phosphorylate HsCyk-4 blocks Ect2 recruitment to the central spindle and the subsequent induction of furrowing.
Microtubules, as well as the microtubule-associated protein (MAP) Prc1, facilitate Plk1 phosphorylation of HsCyk-4.
Characterization of a phosphomimetic version of HsCyk-4 indicates that Plk1 promotes Ect2 recruitment through multiple
targets. Collectively, our data reveal that formation of the HsCyk-4-Ect2 complex is subject to multiple layers of regulation to
ensure that RhoA activation occurs between the segregated sister chromatids during anaphase.
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Introduction
Cell division requires crosstalk between various cell cycle
regulatory proteins and the actomyosin and microtubule cytoskel-
etons. The small GTPase RhoA lies at the interface between these
cytoskeletal systems, and its activation at the equatorial cortex
following chromosome segregation is a critical step in the
specification of the division plane [1]. RhoA activation leads to
a dramatic reorganization of the actomyosin cytoskeleton
underneath the plasma membrane to form a contractile network
necessary for cell cleavage. The spatial regulation of RhoA
activation is largely dictated by the microtubule cytoskeleton,
through the combined action of microtubule asters and a set of
interpolar microtubule bundles termed the central spindle [2]. The
central spindle forms between the divided sister chromatids and
acts as a signaling hub, integrating positional and temporal cues to
facilitate activation of RhoA at the equatorial cortex [3].
The centralspindlin complex, a heterotetramer consisting of the
kinesin-like protein Mklp1 (UniProt Q02241) and the RhoGAP
HsCyk-4/MgcRacGAP (hereafter referred to as HsCyk-4 [Uni-
Prot Q9H0H5]), is required for assembly of the central spindle
[4,5]. In addition to its role in assembly, HsCyk-4 recruits the
RhoGEF Ect2 (UniProt Q9H8V3) to the central spindle [6–9].
HsCyk-4 binds directly to the noncatalytic N terminus of Ect2 in a
phosphorylation-dependent manner [6], via a region possessing
BRCA1 C-terminal (BRCT) repeats. Because the Ect2 N terminus
has been proposed to associate with and inhibit the activity of its
C-terminal GEF domain [10], HsCyk-4 binding may facilitate
both targeting and activation of the exchange factor for RhoA.
Consistent with this model, depletion of either Ect2 or HsCyk-4
prevents RhoA-dependent cortical contractility [6–9]. Hence,
formation of the Ect2–HsCyk-4 complex represents a critical step
in cleavage plane specification, linking positional information from
microtubules with cortical actomyosin contractility through RhoA
activation. Because elevated Cdk1–cyclin B activity prevents
HsCyk-4 and Ect2 binding [6,7], this association is tightly
controlled with respect to the cell cycle such that it occurs only
during late mitosis.
The mammalian Polo-like kinase Plk1 (UniProt P53350) was
shown recently through a complementary series of chemical
genetic and small molecule inhibitor-based studies to be an
essential activator of RhoA [11–14]. Inhibition of Plk1 prevents
PLoS Biology | www.plosbiology.org 1 May 2009 | Volume 7 | Issue 5 | e1000110Ect2 association with HsCyk-4 and blocks its recruitment to the
central spindle [11–14], suggesting that Plk1 might serve as a
stimulatory kinase. Consistent with this, Plk1 phosphorylates Ect2
in vitro, and this phosphorylation may affect its exchange activity
[15].
The functions of Polo-like kinase family members (Plks) are
modulated through their subcellular distribution. Plks are
recruited to various cellular sites through recognition of a
phosphorylated, or primed, substrate [16]. Specifically, a C-
terminal Polo-box domain (PBD) binds to a priming phosphor-
ylation site, which serves to localize and locally activate the Plk
[17,18]. The PBD of Plk1 interacts with hundreds of mitotic
proteins, each with varying affinities, to control different aspects of
cell division [19]. PBD binding to the MAP Prc1 (UniProt
O43663) is reported to be the primary anchor for Plk1 at the
central spindle [20]. However, additional PBD binding sites
independent of Prc1 are present to ensure the anaphase
concentration of Plk1 at the central spindle [15,19,21,22]. Here,
we have examined the mechanism by which Plk1 stimulates
association between Ect2 and HsCyk-4 during anaphase to trigger
the onset of cytokinesis. Our data indicate that Plk1 has multiple
functions in RhoA activation, part of which can be explained
through its phosphorylation of HsCyk-4, and that these functions
are enhanced through its targeting to the central spindle.
Results
Chemical genetic and small-molecule–based inhibition of Plk1
kinase activity prevents both Ect2 association with HsCyk-4 and its
recruitment to the central spindle [11–14]. Therefore, we sought
to understand the mechanism whereby Plk1 regulates formation of
this complex. We have shown previously that the Ect2 N terminus
(Ect2-BRCT) is sufficient to localize to the central spindle [6].
Using the localization of this fragment as an assay, we tested the
possibility that Plk1 may relieve the autoinhibition of Ect2, freeing
the N terminus to associate with HsCyk-4. This model predicts
that the central spindle localization of Ect2-BRCT would be
independent of Plk1 activity. However, the Plk1 inhibitor BI-2536
[23] disrupted Ect2-BRCT localization to the central spindle in
98% of anaphase HeLa cells compared with 8% of DMSO-treated
control cells (n=50 for each) (Figure 1A), suggesting that relieving
Ect2 autoinhibition is not the sole function of Plk1 in controlling
HsCyk-4–Ect2 complex formation.
In addition to localizing to the central spindle when expressed in
cells, a recombinant form of Ect2-BRCT associates with
endogenous HsCyk-4 from mitotic lysates in a phosphorylation-
dependent manner [6]. We therefore used this assay to ask if Plk1
activity is required for this association. First, HsCyk-4 association
with Ect2-BRCT was analyzed in lysates from HeLa cells
synchronously released from a metaphase block. Although only
weak association was detected in metaphase, HsCyk-4, as well as
its binding partner, Mklp1, were precipitated in abundance when
the vast majority of control cells were in anaphase or telophase
(Figure 1B). In contrast, BI-2536 potently inhibited the ability of
recombinant Ect2-BRCT to precipitate either HsCyk-4 or Mklp1
(Figure 1B), suggesting that Plk1 regulates complex formation via
HsCyk-4. To confirm this result, nocodazole-arrested cells were
forced to exit mitosis through application of the Cdk inhibitor
purvalanol A. Treatment of prometaphase cells with purvalanol A
induces assembly of ectopic cleavage furrows in the absence of
chromosome segregation in a manner dependent upon known
cytokinesis regulators [24]. Cdk1 inhibition led to a dramatic
increase in the amount of HsCyk-4 precipitated by Ect2-BRCT
(Figure 1C). Concurrent application of BI-2536 and purvalanol A
potently blocked HsCyk-4 precipitation by Ect2-BRCT and
abrogated ectopic cleavage furrowing (Figure 1C) [12].
Dephosphorylation of mitotic lysates prevents HsCyk-4 precip-
itation by Ect2–BRCT [6]. Hence, we examined whether the
BRCT domains of Ect2 act as a bona fide phosphobinding
module. Mutation of residues within the BRCT domains of Ect2
analogous to those that coordinate phosphate in BRCA1 and
MDC1 [25] abolished precipitation of HsCyk-4 from mitotic
lysates (Figure 1D), confirming that Ect2’s BRCT domains
function as a phosphobinding module akin to those previously
analyzed. Consistent with these biochemical findings, mutation of
these two conserved phosphopeptide coordinating residues
abolished targeting of the Ect2-BRCT domain to the central
spindle in anaphase (Figure 1E).
Our previous findings suggested that the N terminus (Nt) of
HsCyk-4 could associate with Ect2-BRCT in the absence of other
proteins, albeit with relatively low affinity under nonstringent
conditions [6]. In vitro, Plk1 has the ability to phosphorylate both
HsCyk-4-Nt and Ect2-BRCT (Figure 2A and 2B) [15]. Using
purified recombinant proteins and more stringent buffer condi-
tions, we tested whether Plk1 phosphorylation of HsCyk-4-Nt or
Ect2-BRCT could stimulate association with its respective binding
partner. Although Plk1 phosphorylated both proteins to high
stoichiometry as evidenced by a gel mobility shift, only
phosphorylation of HsCyk-4-Nt enhanced the association with
Ect2-BRCT (Figures 2A and S1A).
HsCyk-4-Nt contains seven consensus motifs for Plk1 phos-
phorylation (E/D-X-S/T-j) [26]. To determine which site(s) Plk1
phosphorylates, we utilized two complementary in vitro approach-
es. First, truncations of HsCyk-4-Nt fused to glutathione-S-
transferase (GST) were used as substrates for Plk1. Of the various
truncations tested, Plk1 preferentially phosphorylated the fragment
encompassing amino acids 111–188 (Figure 2B). An array of
HsCyk-4 N-terminal peptides was used to confirm this result and
more precisely define the region of Plk1 phosphorylation. Only
peptides containing amino acids 139–174 of HsCyk-4 were
strongly phosphorylated by Plk1 (Figures 2C and S2A). Within
this region, four putative Plk1 phosphorylation sites (Ser149,
Ser157, Ser164, and Ser170) are well conserved across species and
are clustered in a region downstream of the coiled-coil domain and
Author Summary
The plane of cell division in animal cells is determined by
the position of the mitotic spindle during early anaphase,
but the molecular signaling that leads to proper formation
of the division plane is not fully understood. The actin- and
myosin-rich contractile ring, which physically divides a cell
in two, localizes to the presumptive division plane through
the local activation of a molecular switch protein, RhoA.
RhoA is activated by Ect2, which binds to the protein
complex centralspindlin found on microtubules in the
vicinity of the division plane (the midzone microtubules).
One critical component of centralspindlin is Cyk-4, a
putative negative regulator of RhoA. Here, we have
analyzed the mechanisms that are responsible for target-
ing the RhoA activator Ect2 to the midzone microtubules.
We show that Polo-like kinase 1 (Plk1), in part through the
microtubule-associated protein Prc1, phosphorylates Cyk-
4. Ect2 binds to phosphorylated Cyk-4 and is then able to
activate RhoA and induce proper formation of the
contractile ring. Our study therefore has elucidated
important details of the signaling cascade in animal cells
that ensures proper division-plane formation.
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PLoS Biology | www.plosbiology.org 2 May 2009 | Volume 7 | Issue 5 | e1000110Figure 1. Inhibition of Plk1 prevents association of HsCyk-4 with Ect2–BRCT. (A) HeLa cells transfected with H2O (control) or CMV-Myc-Ect2-
BRCT (myc-BRCT) were synchronized in anaphase using an MG132 arrest/release protocol. Following treatment with 100 nM BI-2536 or DMSO, cells
were fixed and stained with antibodies to Myc and a-tubulin, and DNA was stained with DAPI. (B) HeLa cells, released into anaphase from an MG132
block, were treated with 100 nM BI-2536 or DMSO and harvested at the time points indicated above the lanes. Lysates and Ect2-BRCT–bound
fractions were probed with antibodies to HsCyk-4 and Mklp1. The percentages of anaphase and telophase cells and of cells with ingressing furrows
are indicated below the corresponding lanes. (C) HeLa cells arrested in prometaphase with nocodazole were treated with DMSO, 22.5 mM purvalanol
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were previously identified in a proteomic screen for phosphory-
lated mitotic spindle proteins (Ser164 and Ser170) [27]. Mutation
of any of these four residues alone was insufficient to prevent Plk1-
stimulated binding (Figure S1B). Therefore, these residues were
mutated, in combination, to nonphosphorylatable Ala residues
and assayed for Plk1-stimulated association with Ect2. In vitro
phosphorylation of HsCyk-4-4A (amino acids 111–188) by Plk1
was dramatically reduced, to below 5% of the wild-type fragment
(Figure S2B). Importantly, mutation of these four residues
effectively disrupted the Plk1-mediated stimulation of HsCyk-4–
Ect2-BRCT complex formation (14.9%68.3% of wild-type
association) (Figure 2E). Conversely, mutation of these four serine
residues to Asp (HsCyk-4-4D) to mimic the phosphorylated state
generated a form of HsCyk-4 capable of associating with Ect2-
BRCT even in the absence of Plk1 phosphorylation (Figure 2E).
Whereas Plk1 phosphorylation of HsCyk-4-wt stimulated associ-
ation with Ect2-BRCT 20.262.8-fold, HsCyk-4-4A and HsCyk-4-
4D produced fold increases of only 3.160.9 and 1.760.5,
respectively, suggesting that the identified residues account for
the vast majority of Plk1-mediated stimulation. Yeast two hybrid
analysis confirmed that HsCyk-4-4D possessed an increased
affinity for Ect2-BRCT (Figure S3). We conclude that Plk1
phosphorylates multiple serine residues in the N terminus of
HsCyk-4 in vitro, thereby stimulating its association with Ect2.
To confirm that Plk1 phosphorylates these sites in vivo as well as
to determine their spatial and temporal regulation, we obtained
phosphospecific antibodies directed at Ser170 in HsCyk-4.
Phospho-Ser170 antibodies specifically stained the central spindle
of control, but not HsCyk-4–depleted, anaphase cells (Figure 2F).
Application of BI-2536 abolished phospho-Ser170 central spindle
staining, providing further evidence that Plk1 is the major kinase
responsible for generating phosphorylated Ser170 in vivo.
We next tested whether Plk1 phosphorylation of HsCyk-4 is
essential for cleavage furrow formation. To address this, we
created stable HeLa cell lines expressing RNA interference
(RNAi)-resistant derivatives of HsCyk-4 fused to EGFP at its C
terminus. Although variability in expression level existed within
and between lines (Figure 3A), each line expressed HsCyk-4–
EGFP in at least 70% of cells (Figure S4A). All HsCyk-4–EGFP
derivatives, despite being expressed above endogenous levels,
localized to the central spindle in cells depleted of endogenous
HsCyk-4 (Figures 3D, 4A, 4C, S4A, S4B, and S4C), indicating
that they retain basic functionality. Additionally, central spindle
assembly remained unperturbed as indicated by proper Prc1
localization in each of the cell lines (Figure S4B). Phospho-Ser170
antibodies were used to confirm the absence of Plk1 phosphor-
ylation in HsCyk-4-4A–EGFP stable cells (Figure S4C).
We analyzed the ability of the HsCyk-4–EGFP derivatives to
rescue the cytokinesis defect associated with depletion of the
endogenous protein. Cytokinesis failure was scored both in fixed
cell populations (Figure 3B) and by live cell imaging of individual
cells (Figure 3C and 3D). In both cases (and all subsequent
experiments), cells were transfected with small interfering RNA
(siRNA) to deplete endogenous HsCyk-4 for between 28 and 32 h
(knockdown=21.3%67.4% of endogenous levels, Figure S4D). In
bulk populations, a wild-type copy of HsCyk-4–EGFP was able to
largely rescue the cytokinesis failure of endogenous HsCyk-4
depletion (20.7%61.1% versus 66.7%61.5% cytokinesis failure),
whereas expression of EGFP alone failed to rescue (65.2%60.2%
cytokinesis failure) (Figure 3B). The Plk1 phospho-site mutants
differed markedly in their abilities to restore efficient cytokinesis:
HsCyk-4-4A–EGFP failed to rescue (59.4%63.2% cytokinesis
failure), whereas HsCyk-4-4D–EGFP rescued to a similar extent as
wild type (16.7%60.7% cytokinesis failure) (Figure 3B). In
individual live cells depleted for endogenous HsCyk-4, expression
of EGFP alone or HsCyk-4-4A–EGFP failed to restore cleavage
furrow formation in 67% (n=9) and 47% (n=32) of cells,
respectively (Figure 3C and 3D). In contrast, 100% of HsCyk-4-
wt–EGFP (n=15) and HsCyk-4-4D–EGFP (n=23) expressing
cells formed proper cleavage furrows and successfully completed
cytokinesis. Similar results were obtained from cells cotransfected
with HsCyk4 siRNA and HsCyk-4-EGFP-wt/-4A/-4D expression
plasmids (Figure S5A). We conclude that phospho-site mutants of
HsCyk-4 that fail to associate with Ect2 in vitro block cleavage
furrow formation in vivo.
To more fully characterize the cytokinetic defect caused by the
nonphosphorylatable allele of HsCyk-4, we examined the
localization of critical cytokinetic regulators during anaphase in
individual fixed cells. As was the case with all single-cell
experiments, only cells expressing the transgenes at comparable
levels were scored for phenotypic analysis (Figure S6B and S6D).
First, we examined Ect2 localization in cells expressing HsCyk-4–
EGFP derivatives. Although Ect2 was recruited to the central
spindle by HsCyk-4-wt–EGFP and HsCyk-4-4D–EGFP during
anaphase (97.8% and 95.4%, respectively, see Figure S6A for
method of assessing localization), a positive Ect2 central spindle
signal was not detected in nearly 90% (n=96) of anaphase cells
expressing HsCyk-4-4A–EGFP (Figures 4A, S6A, and S6B).
Similarly, while recombinant Ect2-BRCT precipitated HsCyk-4-
wt–EGFP and HsCyk-4-4D–EGFP from purvalanol A–treated
cells, Ect2-BRCT failed to precipitate either EGFP alone or
detectable amounts of HsCyk-4-4A–EGFP when stably expressed
(Figure 4B). To exclude the possibility that the reduced level of
HsCyk-4-4A–EGFP expression precluded our ability to detect its
association with Ect2-BRCT, we transiently transfected HsCyk-4–
EGFP derivatives to approximately equal levels and confirmed the
absence of detectable association of HsCyk-4-4A–EGFP with
recombinant Ect2-BRCT in purvalanol A-treated cells (Figure
S5B). Consistent with its central role in cleavage furrow formation,
RhoA localization to the equatorial cortex was perturbed in cells
stably expressing HsCyk-4-4A–EGFP (Figure 4C). To quantita-
tively examine a requirement for Plk1 phosphorylation of HsCyk-4
in RhoA activation, we examined the localization of Anillin, a
factor that requires active RhoA signaling for its localization to the
equatorial cortex [7,28]. Cortical accumulation of Anillin was
disrupted in nearly half of all anaphase cells stably expressing
HsCyk-4-4A–EGFP (Figure S6C and S6D). We conclude that
Plk1 phosphorylation of the N terminus of HsCyk-4 is necessary to
mediate association with Ect2 and promote RhoA activation in
vivo. The phenotype associated with HsCyk-4-4A–EGFP expres-
sion is highly reminiscent of Plk1 inhibition [11–14], suggesting
A, 100 nM BI-2536, or 22.5 mM purvalanol A + 100 nM BI-2536 for 30 min. Lysates (,5%) and Ect2-BRCT bound fractions were probed with antibodies
to HsCyk-4, cyclin B1, and a-tubulin. (D) Lysates were prepared from HeLa cells synchronized by nocodazole block, incubated with the indicated
immobilized derivatives of Ect2-BRCT, washed, and separated on SDS-PAGE. Lysates (,5%) and Ect2-BRCT bound fractions were probed with
antibodies to HsCyk-4 (upper blots). Sequence alignment showing conservation of phosphate coordinating residues in the indicated BRCT-domain
containing proteins (lower sequences). (E) HeLa cells were transfected with vector (control), CMV-Myc-Ect2-BRCT (wt), or CMV-Myc-Ect2-BRCT T153A/
K195M (TA/KM). Cells were fixed 8 h after release from thymidine, and stained with DAPI and antibodies to Myc and a-tubulin. Scale bars in this and
all other figures represent 10 mm.
doi:10.1371/journal.pbio.1000110.g001
Plk1 Regulation of Cytokinesis
PLoS Biology | www.plosbiology.org 4 May 2009 | Volume 7 | Issue 5 | e1000110Figure 2. Plk1 phosphorylates multiple serine residues in HsCyk-4-Nt to stimulate association with Ect2-BRCT. (A) Schematic of
experimental design (upper diagram). Recombinant HsCyk-4-Nt or Ect2-BRCT fused to CBD was incubated in the presence (+) or absence (2) of Plk1-
T210D kinase domain and ATP. Soluble HsCyk-4-Nt or Ect2-BRCT was added to the washed beads, mixed, and then separated on SDS-PAGE and
Coomassie stained for visualization. Input represents 50% of the total soluble protein incubated with immobilized protein. (B) Immobilized GST and a
series of GST–HsCyk-4 truncated proteins as indicated were incubated with full-length recombinant Plk1 T210D (KA) or Plk1 K82M/T210D (KD) and
[c-
32P] ATP. Proteins were separated on SDS-PAGE and Coomassie stained for visualization. Incorporation of
32P was visualized by autoradiography.
(C) Peptide arrays containing 142 18-mer peptides covering amino acids 1–300 of HsCyk-4 were incubated with recombinant full-length Plk1 T210D
or kinase-dead Plk1 K82M/T210D and [c-
32P] ATP. Incorporated
32P was visualized by autoradiography and the intensity at each peptide spot was
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PLoS Biology | www.plosbiology.org 5 May 2009 | Volume 7 | Issue 5 | e1000110Figure 3. Plk1 phosphorylation of HsCyk-4 is essential for cleavage furrow formation. (A) The indicated stable HeLa cell lines and control
HeLa cells were transfected with siRNA to deplete endogenous HsCyk-4. At 32 h post-transfection, lysates were prepared, separated on SDS-PAGE,
and probed with antibodies to HsCyk-4, GFP, and a-tubulin. (B) The indicated stable cell lines and control HeLa cells were transfected with siRNA to
deplete endogenous HsCyk-4. 32 h post-transfection cells were fixed and stained with GFP and a-tubulin antibodies, and DNA was stained with DAPI.
Failed cytokinesis events were scored from the percentage of bi- or multinucleated GFP-positive interphase cells relative to the total population of
GFP-positive cells (n$300). Error bars represent standard deviation from two independent experiments. (C) The indicated stable cells transfected with
siRNA to deplete endogenous HsCyk-4 were filmed by live video microscopy and scored for the indicated phenotypes. Only those cells expressing
HsCyk-4–EGFP with a maximum intensity value above 2,000 over background fluorescence were scored for phenotype. The total number of cells
scored for each cell line: EGFP, n=9; wt, n=15; 4A, n=32; 4D, n=23. (D) Nomarski and GFP time-lapse images from (C) are shown from early
anaphase (1 min post metaphase exit) through late telophase (13 min post metaphase exit) for the indicated stable cells lines. Because of high levels
of expression, EGFP stable cells were filmed using reduced exposure times.
doi:10.1371/journal.pbio.1000110.g003
quantified and plotted relative to the position of the peptide across the array. (D) Schematic representation of HsCyk-4 functional domains (C-C,
coiled-coil domain; C1, C1 domain; GAP, GTPase activating protein domain). The red box indicates the predicted Plk1 target peptide sequence
identified from the array analysis (amino acids 139–174). Within this region, Ser149, Ser157, Ser164, and Ser170 are shaded to indicate those residues
mutated in the HsCyk-4 derivatives analyzed in (E). (E) Recombinant HsCyk-4-Nt and indicated derivatives fused to CBD were assayed for Plk1
phosphorylation and Ect2-BRCT binding as in (A). Fold stimulation (6 standard error of the mean) of Ect2-BRCT binding to HsCyk-4-Nt upon Plk1
phosphorylation was determined from at least three independent experiments (bar graph). (F) HeLa cells transfected with H2O (control) or siRNA to
deplete endogenous HsCyk-4 were synchronized in anaphase using an MG132 arrest/release protocol. Following treatment with 100 nM BI-2536 or
DMSO, cells were fixed and stained with phospho-Ser170 antibodies, and DNA was stained with DAPI.
doi:10.1371/journal.pbio.1000110.g002
Plk1 Regulation of Cytokinesis
PLoS Biology | www.plosbiology.org 6 May 2009 | Volume 7 | Issue 5 | e1000110that, with respect to cleavage furrow formation, HsCyk-4 is a
relevant target of Plk1’s kinase activity.
If the primary function of Plk1 in generating the HsCyk-4-Ect2
complex is to phosphorylate HsCyk-4, then HsCyk-4-4D–EGFP
should be able to associate with Ect2 in the absence of Plk1 kinase
activity. To test this possibility, wild type and HsCyk-4-4D–EGFP
stable cells were induced to exit mitosis with addition of purvalanol
A in the presence and absence of BI-2536. HsCyk-4-4D–EGFP
retained the ability to be precipitated by Ect2-BRCT despite the
presence of BI-2536, whereas the association of wild-type HsCyk-
4–EGFP with Ect2–BRCT was sensitive to the inhibitor
(Figure 5A). Surprisingly, although HsCyk-4-4D–EGFP copreci-
pitated with Ect2-BRCT in the presence of BI-2536, endogenous
Ect2 was not recruited to the central spindle during anaphase of
BI-2536 treated HsCyk-4-4D–EGFP cells (Figure 5B, upper
images). As a likely consequence, HsCyk-4-4D–EGFP expression
did not prevent BI-2536-induced cytokinesis failure (Figure 5B,
lower images). These data suggest that Plk1 likely phosphorylates
multiple targets essential for cytokinesis, and that the regulated
association between HsCyk-4 and Ect2 at the central spindle
requires other Plk1-dependent steps in addition to HsCyk-4
phosphorylation. Because Plk1 is known to phosphorylate the C
terminus of Ect2 [15], we asked whether the Ect2-BRCT
fragment could localize independently of Plk1 activity in HsCyk-
4-4D–EGFP cells. Whereas less than 2% of cells expressing Myc-
tagged Ect2-BRCT localized the truncated protein to the central
spindle in BI-2536-treated HsCyk-4-wt–EGFP expressing cells,
those expressing HsCyk-4-4D–EGFP retained Ect2-BRCT local-
ization in 16.2%67.1% of BI-2536 treated anaphase cells
(Figure 5C). We conclude that while Plk1 phosphorylation of
the N terminus of HsCyk-4 is necessary and to a certain extent
sufficient to mediate association with Ect2-BRCT, other Plk1-
dependent events, occurring at least partially through the C
terminus of Ect2, are necessary for its recruitment to the central
spindle.
Having established that HsCyk-4 phosphorylation by Plk1 is
critical for cleavage furrow formation, we next investigated how
this phosphorylation is regulated. Plk1 substrate binding is often
Figure 4. Phosphorylation of HsCyk-4 is necessary for Ect2 association. (A) The indicated stable cell lines transfected with siRNA to deplete
endogenous HsCyk-4 were fixed and stained with Ect2 and GFP antibodies, and DNA was stained with DAPI. Percentages indicate the fraction of
anaphase cells displaying ‘‘positive’’ Ect2 central spindle localization (n$90 cells) as defined in Materials and Methods. (B) The indicated stable cell
lines transfected with siRNA to deplete endogenous HsCyk-4 were synchronized with nocodazole, at which point 22.5 mM purvalanol A was added to
the cells. Lysates and Ect2-BRCT–bound fractions were separated by SDS-PAGE and probed with antibodies to HsCyk-4, GFP, and a-tubulin. Lysate
represents approximately 5% of input. (C) The indicated stable cell lines transfected with siRNA to deplete endogenous HsCyk-4 were fixed and
stained with antibodies to RhoA and GFP, and DNA was stained with DAPI.
doi:10.1371/journal.pbio.1000110.g004
Plk1 Regulation of Cytokinesis
PLoS Biology | www.plosbiology.org 7 May 2009 | Volume 7 | Issue 5 | e1000110mediated through binding of the PBD to a phosphorylation site on
the target protein. However, we did not find appreciable amounts
of HsCyk-4 associated with either endogenous Plk1 or with
recombinant PBD during forced mitotic exit (Figure S7A and
S7B), a time when HsCyk-4 serves as a substrate for Plk1. In
contrast, the MAP Prc1 associated with endogenous Plk1 as well as
recombinant PBD during forced mitotic exit (Figure S6A and S6B)
and, together with Mklp2, promotes Plk1 recruitment to central
spindle microtubules during anaphase [20,21]. In addition, Prc1
colocalizes with centralspindlin and direct association with HsCyk-
4 has been reported [29–31], raising the possibility that it might
serve as an intermediary in the phosphorylation of HsCyk-4.
Because Ect2-BRCT precipitates HsCyk-4 in lysates from
purvalanol A–treated cells, a reaction requiring Plk1 activity
(Figure 1C), we were able to ask whether Prc1 was required
for efficient Ect2-BRCT precipitation of HsCyk-4. The amount
of HsCyk-4 precipitated in Prc1-depleted cells (knock-
down=21.5%65.0% of endogenous Prc1 levels) was significantly
decreased relative to control cells (Figure 6A). The inability of
Prc1-depleted cells to generate phosphorylated HsCyk-4 provided
a molecular explanation for the failure of HsCyk-4 to associate
with Ect2-BRCT (Figure 6B). Consistent with the interpretation
that Prc1 functions by facilitating the phosphorylation of HsCyk-4
by Plk1, expression of HsCyk-4-4D–EGFP bypassed the require-
ment for Prc1 to permit HsCyk-4 precipitation by Ect2-BRCT
(Figure 6C).
Figure 5. Plk1 utilizes multiple mechanisms to promote Ect2 central spindle localization. (A) The indicated stable cell lines transfected
with siRNA to deplete endogenous HsCyk-4 were synchronized with nocodazole, at which point 22.5 mM purvalanol A was added to the cells in the
presence or absence of 100 nM BI-2536. Lysates and Ect2-BRCT–bound fractions were separated by SDS-PAGE and probed with antibodies to HsCyk-4
and a-tubulin. Lysate represents approximately 5% of input. (B) The indicated stable cell lines were transfected with siRNA to deplete endogenous
HsCyk-4 and synchronized in anaphase using an MG132 arrest/release protocol. Following treatment with 100 nM BI-2536, cells were fixed and
stained with GFP and Ect2 antibodies, and DNA was stained with DAPI (upper images). Percentages indicate the fraction of anaphase cells displaying
positive central spindle accumulation of Ect2 (n$50 cells). The indicated stable cell lines transfected with siRNA to deplete endogenous HsCyk-4 were
synchronized using an MG132 arrest/release protocol (lower bar graph). Following treatment with DMSO (2) or 100 nM BI-2536 (+) for 12–16 h, cells
were fixed and stained with antibodies to GFP and a-tubulin, and DNA was stained with DAPI. Failed cytokinesis events were scored from the
percentage of bi- or multinucleated GFP-positive interphase cells relative to the total GFP-positive population (n$100). (C) The indicated stable cell
lines cotransfected with CMV-Myc-Ect2-BRCT (myc-BRCT) and siRNA to deplete endogenous HsCyk-4 were synchronized in anaphase using an MG132
arrest/release protocol. Following treatment with 100 nM BI-2536 or DMSO, cells were fixed and stained with antibodies to Myc and a-tubulin, and
DNA was stained with DAPI. Percentages indicate the fraction of anaphase cells displaying proper Ect2-BRCT central spindle localization (n$50 cells).
doi:10.1371/journal.pbio.1000110.g005
Plk1 Regulation of Cytokinesis
PLoS Biology | www.plosbiology.org 8 May 2009 | Volume 7 | Issue 5 | e1000110A direct association between Prc1 and HsCyk-4 may
functionally link Plk1 kinase activity with the N terminus of
HsCyk-4. To test this possibility, a mutant of Prc1 (Prc1-ST601/
2AA) incapable of Plk1 recruitment to the central spindle was
expressed in cells depleted for endogenous Prc1 [20]. As
previously reported, Prc1-ST601/2AA did not detectably
interact with Plk1 (Figure S8B). Despite the disruption in
Plk1–Prc1 association, Plk1 central spindle localization was only
moderately attenuated (Figure S8A), and phosphorylated HsCyk-
4 on Ser170 persisted at the central spindle (Figure S8C).
Although this reduced level of Plk1 at the central spindle could
suffice for HsCyk-4 phosphorylation, these data suggest that Plk1
need not associate directly with Prc1 in order to phosphorylate
HsCyk-4.
Figure 6. Prc1 is required for Plk1-mediated stimulation of the HsCyk-4-Ect2 complex. (A) Control HeLa cells, or those transfected with
siRNA to deplete endogenous Ect2 and Prc1, were synchronized in S-phase with thymidine or in prometaphase with nocodazole. Cells were treated
with DMSO or 22.5 mM purvalanol A. Lysates and Ect2-BRCT–bound fractions were separated on SDS-PAGE and probed with antibodies to HsCyk-4, a-
tubulin, Ect2, and Prc1. Lysate represents approximately 5% of input. (B) HeLa cells were either mock transfected or transfected with siRNA to deplete
Prc1, and synchronized in prometaphase with nocodazole. Cells were released from the prometaphase block by either addition of 22.5 mM purvalanol
A or replacement with fresh medium and harvested 60 min post-release. Lysates and HsCyk-4 immunoprecipitates were separated on SDS-PAGE.
Blots were probed with antibodies to HsCyk-4 and phospho-Ser170. (C) The indicated stable cell lines transfected with siRNA to deplete endogenous
HsCyk-4 and Prc1, as indicated, were synchronized in prometaphase with nocodazole, at which point cells were treated with 22.5 mM purvalanol A.
Lysates and Ect2-BRCT–bound fractions were separated on SDS-PAGE and probed with antibodies to HsCyk-4, Prc1, and a-tubulin. Lysate represents
approximately 5% of input. Asterisks indicate the position of cross-reacting species in recombinant CBD-Ect2-BRCT recognized by Prc1 antibodies. (D)
HeLa cells were synchronized with 0.04 mg/ml nocodazole, at which point either DMSO or nocodazole was added to a final concentration of 5 mg/ml
in the presence of 22.5 mM purvalanol A. Lysates and Ect2-BRCT–bound fractions were separated on SDS-PAGE and probed with antibodies to HsCyk-
4, cyclin B1, and a-tubulin (upper gels). Lysate represents approximately 5% of input. HeLa cells, synchronized and treated as above, were fixed and
stained with antibodies to HsCyk-4 and a-tubulin, and DNA was stained with DAPI (lower images).
doi:10.1371/journal.pbio.1000110.g006
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on a microtubule-based scaffold, Prc1-mediated bundling of
microtubules may facilitate phosphorylation of HsCyk-4 by Plk1.
To test this possibility, we asked whether microtubule disruption
would influence the ability of Ect2-BRCT to precipitate
endogenous HsCyk-4. Low-dose nocodazole treatment (0.04 mg/
ml), which only weakly disrupted the microtubule cytoskeleton and
retained HsCyk-4 microtubule association, permitted robust
precipitation of HsCyk-4 by Ect2-BRCT upon purvalanol A
addition (Figure 6D). However, 5 mg/ml nocodazole caused full
microtubule destabilization, delocalized HsCyk-4, and rendered
HsCyk-4 association with Ect2-BRCT undetectable (Figure 6D),
underscoring the importance of a microtubule platform for this
association.
Although these data implicate both Prc1 and a microtubule
scaffold as critical regulators of RhoA activation by modulating
Plk1 phosphorylation of HsCyk-4, cells depleted for Prc1 can form
ingressing cleavage furrows [30,32] and those depleted of
microtubules retain contractility [33], indicating that Prc1 and
microtubules are not strictly essential for RhoA activation upon
mitotic exit. Both prometaphase cells and cells containing
monopolar spindles that are forced out of mitosis have more
stringent requirements for the formation of cleavage furrows
[24,34], suggesting that the process is less robust under these
circumstances. We therefore induced prometaphase cells to exit
mitosis with purvalanol A and asked whether Prc1 was required
for cortical RhoA localization and ectopic cleavage furrow
formation. Indeed, in this context, Prc1 depletion severely
compromised RhoA-induced contractility (Figure 7A). We con-
clude that Prc1 facilitates Plk1 phosphorylation of HsCyk-4 to
allow recruitment of Ect2 to the central spindle where it can
stimulate the local activation of RhoA. These data suggest that
other mechanisms can compensate for the absence of Prc1 during
bipolar cytokinesis.
Discussion
The central spindle serves as a platform for the coordinated
recruitment of numerous signaling proteins that regulate cytoki-
nesis [35]. The Plk1-mediated recruitment of the RhoGEF Ect2 to
the central spindle by the RhoGAP HsCyk-4 component of
centralspindlin appears to be a critical step in the generation of a
localized band of cortical RhoA to a region just overlying the
central spindle [11–14]. Here, we provide a molecular mechanism
whereby the HsCyk-4-Ect2 complex is formed at the central
spindle following anaphase onset. By combining a reconstituted
system with cell-based analyses, we have demonstrated that Plk1
promotes the phosphorylation of the N terminus of HsCyk-4, thus
generating a phospho-epitope recognized by the BRCT domains
of Ect2. BRCT binding may relieve Ect2 autoinhibition and
facilitate activation of its intrinsic exchange activity toward RhoA.
Indeed, stimulation of the HsCyk-4-Ect2 complex formation by
Figure 7. Ectopic cleavage furrowing during forced mitotic exit requires Prc1. (A) HeLa cells were either mock transfected (control) or
transfected with siRNA to deplete the indicated protein and synchronized in prometaphase with nocodazole. Ectopic cleavage furrow formation and
RhoA activation were induced with addition of 22.5 mM purvalanol A for 30 min. Cells were fixed and stained with antibodies to RhoA, and DNA was
stained with DAPI. Percentages of cells undergoing ectopic cleavage furrow formation were determined as a function of RhoA cortical recruitment in
100 cells. (B) Proposed model. At the central spindle, microtubules are bundled through the combined efforts of the centralspindlin complex and the
MAP Prc1. Factor X, which could be Prc1, Mklp2, centralspindlin, or an unknown factor, recruits Plk1 to the central spindle through association with its
PBD, freeing the kinase domain to phosphorylate substrates at the central spindle (e.g., HsCyk-4, Ect2). Plk1 phosphorylation of HsCyk-4 is not
sufficient for Ect2 recruitment to the central spindle, but requires other Plk1-dependent processes, at least one of which may be the relief of Ect2
autoinhibition. GAP, HsCyk-4; GEF, Ect2.
doi:10.1371/journal.pbio.1000110.g007
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cleavage furrow formation. Our data also demonstrate that the
role of Plk1 in stimulating HsCyk-4–Ect2 association is not limited
to phosphorylation of HsCyk-4, but rather may also involve relief
of Ect2 autoinhibition. Furthermore, we have identified the
microtubule-associated protein (MAP) Prc1 and microtubules as
critical factors facilitating Plk1 phosphorylation of HsCyk-4.
Collectively, our work has elucidated a molecular basis for Plk1-
regulated cleavage furrow formation and has provided further
evidence that central spindle microtubules act as a crucial
signaling center for cytokinesis (Figure 7B).
In order to stimulate association with the BRCT domains of
Ect2, Plk1 targets multiple serine residues within the N terminus of
HsCyk-4. While BRCT–phosphopeptide interactions have only
been modeled with a single phosphorylated residue [36], it is
possible that the tandem BRCT domains of Ect2 contact multiple
phosphorylated residues. However, because mutation of the
equivalent residues in Ect2 that coordinate the phosphate in
MDC1 and BRCA1 [25] abrogates binding to HsCyk-4, we do
not favor this possibility. Alternatively, phosphorylation of multiple
residues within HsCyk-4 may lead to a conformational change that
favors recognition of one particular phosphoserine by the BRCT
domains of Ect2. Consistent with this, mutation of Ser157 alone
within HsCyk-4 abolished association with Ect2-BRCT in mitotic
lysates (unpublished data). Still, as mutation of any one of the
serine residues was insufficient to prevent Plk1 stimulation of the
HsCyk-4-Ect2 association in vitro, these data are not in complete
accordance with one another. Instead, the most plausible
explanation of these results is that each of the four phosphoserine
residues within the cluster contributes to the overall binding
affinity, perhaps by facilitating rebinding upon dissociation.
We have shown that the BRCT repeats of Ect2 can bind a
phosphomimetic allele of HsCyk-4 (4D) from Plk1-inhibited
mitotic lysates, suggesting a rather simple pathway for regulation
of HsCyk-4 by Plk1. However, despite premature Ect2 association
with HsCyk-4-4D in early mitotic cells (unpublished data), RhoA-
induced cortical contractility was not observed. These data suggest
that further steps are necessary to form a complex competent for
triggering contractile events. One such step may be the removal of
inhibitory Cdk1-cyclin B phosphorylations [6,7]. Additionally,
Plk1 phosphorylation of HsCyk-4 is necessary, but not sufficient,
for Ect2 central spindle recruitment. As appreciable central spindle
localization of isolated BRCT domains can occur in Plk1-inhibited
cells expressing phosphomimetic HsCyk-4, Plk1 may also function
to relieve Ect2 autoinhibition [15]. However, the recruitment of
this N-terminal fragment of Ect2 is far more efficient in the
presence than in the absence of Plk1 activity, suggesting the
involvement of additional Plk1 substrates and additional modes of
regulation. Indeed, a number of other Plk1 substrates are involved
in cytokinesis, including Rock2 [19], Anillin [19], and an
additional exchange factor for RhoA, MyoGEF [37]. Further
work is required to define the full spectrum of Plk1 substrates
required for complete activation of RhoA during cytokinesis.
Our biochemical results, obtained with synchronized cells
forced out of mitosis, reveal that Prc1 and a microtubule scaffold
are critical for robust generation of phosphorylated HsCyk-4.
Because Prc1 recruits Plk1, and because Prc1 and HsCyk-4
colocalize at the central spindle [20,29,30,32,38,39], it is possible
that docking of Plk1 on Prc1 allows the kinase to phosphorylate
HsCyk-4 while bound to Prc1. While we cannot exclude this
possibility, HsCyk-4 phosphorylation persisted in cells expressing a
Prc1 derivative lacking the previously defined Plk1 docking sites
[20]. One important caveat is that these mutations did not
completely abrogate Plk1 recruitment to the central spindle. This
diminished Plk1 localization may arise through an alternative
pathway, perhaps through association with Mklp1, Mklp2, or
HsCyk-4 itself (Figure 7B) [19,21,22]. These modes of Plk1
recruitment may provide a sufficient amount of localized kinase
activity to generate a biologically relevant pool of phosphorylated
HsCyk-4. Because these mutations still allow microtubule
bundling, Prc1 may create a scaffold of appropriately bundled
microtubules on which Plk1 can target HsCyk-4 for phosphory-
lation. In a manner analogous to the phosphorylation of Mklp2
[21], microtubules may also enhance Plk1-mediated phosphory-
lation of HsCyk-4.
While in vivo analyses of bipolar cytokinesis events indicate that
depletion of either Ect2, RhoA, or HsCyk4, as well as Plk1
inhibition and prevention of HsCyk-4 phosphorylation, all result
in complete abrogation of cortical contractility [6–14,28],
depletion of Prc1 does not cause such a severe phenotype
[20,39]. In contrast, our biochemical analyses using prometaphase
cells forced out of mitosis indicate that Prc1 is critical for
generating significant amounts of phosphorylated HsCyk-4. Prc1
depletion in normally dividing cells results in a dramatically
disorganized central spindle and a delocalization of cytokinetic
factors such as Plk1 and HsCyk-4 [20,30,32], rendering an
examination into the localization of the phosphorylated form of
HsCyk-4 equivocal. Additionally, while Prc1 depletion does not
block furrowing in bipolar cells, it does greatly attenuate ectopic
cleavage furrowing induced by purvalanol A treatment of
prometaphase cells. A similar scenario occurs in cells depleted
for Mklp1. Whereas its depletion causes a furrowing defect in only
40%–50% of anaphase cells and allows generation of active RhoA
[6,8], loss of Mklp1 during forced mitotic exit almost completely
abrogates the formation of ectopic cleavage furrows and the
recruitment of RhoA to the cortex (unpublished data). Thus, the
phenotypes resulting from a reduction in RhoA activation are
likely to be context dependent, with the ectopic cleavage furrowing
induced by purvalanol A perhaps being particularly dependent on
events that occur on bundled microtubules [34,40,41].
In summary, our data reveal that many levels of protein
phosphorylation regulate the activation of RhoA upon anaphase
onset. The recruitment of critical central spindle components such
as Prc1 and centralspindlin, as well as the formation of the HsCyk-
4-Ect2 complex, are negatively regulated by Cdk1–cyclin B–
mediated phosphorylation [6,20,39,42,43]. Following a decline in
Cdk1–cyclin B activity at anaphase onset, microtubules are
bundled and Plk1 is recruited to the central spindle through
association of its PBD with Prc1 [20], Mklp2 [21], and possibly
other factors [19,22]. At the central spindle, Plk1 performs several
functions critical for cleavage furrow formation, including HsCyk-
4 phosphorylation and subsequent Ect2 recruitment, as well as
activation of RhoA. These multiple layers of regulation conspire to
ensure that activation of the cytokinetic machinery occurs at the
appropriate time and place.
Materials and Methods
Cell Culture and Drug Treatment
Kyoto HeLa S3 cells were grown in Dulbecco’s Modified Eagle
Medium (DMEM) supplemented with 10% FBS, 2 mM L-
glutamine, 100 U penicillin, and 0.1 mg/ml streptomycin. Stable
cell lines expressing siRNA-resistant HsCyk-4–EGFP and deriv-
atives were constructed in HeLa cells grown in DMEM containing
200 mg/ml hygromycin B. Previously described dsRNAs were
used in this study to deplete endogenous HsCyk-4 [6], Ect2 [6],
and Prc1 [20]. Oligofectamine (Invitrogen) and Lipofectamine-
2000 (Invitrogen) were used for transfection of siRNA and plasmid
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Nocodazole (Sigma) was used at 0.04 mg/ml to mildly perturb the
microtubule cytoskeleton and arrest cells in prometaphase, and at
5 mg/ml to fully deplete the microtubule cytoskeleton. BI-2536
(generously provided by Norbert Kraut, Boehringer Ingelheim)
was used at 100 nM [23]. MG132 (Sigma) was used at 10 mM.
Live Imaging and Immunofluorescence
To perform live cell imaging analysis, cells were grown in the
Delta T4 open dish system (BiOptechs) and controlled at 37uC
during the filming process. Cells were visualized using a 406/.75
NA objective on a Zeiss Axiovert 200M equipped with a
Yokogawa CSU-10 spinning-disk unit (McBain), illuminated with
a 50 mW 473 nm DPSS laser (Cobolt). Single-plane multipoint
acquisitions were captured every 20 s on a Cascade 512B EM-
CCD camera (Photometrics) using MetaMorph (Molecular
Devices) software. All images were acquired under identical
conditions and scaled and processed identically (with the exception
of EGFP stable cells, which were acquired using a reduced
exposure). Cells were considered to be ‘‘positive’’ for transgene
expression if the maximum intensity of cellular fluorescence was
.2,000 above the background intensity. For immunofluorescence
analysis, cells were grown on coverslips and fixed with methanol at
220uC for either 15 min or overnight (for Anillin, Ect2, GFP,
Myc, phospho-Ser170, Plk1, and Prc1 staining) or with 10%
trichloroacetic acid on ice for 15 min (for RhoA, GFP, HsCyk-4,
and a-tubulin staining). Fluorescently conjugated secondary anti-
mouse or anti-rabbit (Alexa 488 or 568, Molecular Probes)
antibodies were used at 1:500 dilutions. Images were collected
with a Zeiss AxioImager M1 microscope using a 406/0.75
objective. All images were acquired under identical conditions
using Metamorph (Molecular Devices) software. The 16-bit
images were then opened in Image J and scaled to 8-bit with a
single scale for all images in a given experiment. For analysis of
Ect2 localization to the central spindle, quantification was
performed as follows: using raw image data acquired under
identical conditions, the fluorescence intensity of Ect2 in a region
of interest (ROI) containing the central spindle was quantified.
From that value, we subtracted the average of ROIs immediately
adjacent to the central spindle. Should the resulting value be
$1,000, then Ect2 central spindle localization was deemed
‘‘positive.’’ A similar scheme was used to determine ‘‘positive’’
Anillin localization to the equatorial cortex. Specifically, using raw
image data acquired under identical conditions, the fluorescence
intensity of Anillin in a ROI containing the equatorial cortex as
well as a ROI in the cytoplasm that was immediately adjacent to
the equatorial cortex were quantified. When the ratio of the
equatorial ROI to cytoplasmic ROI was greater than 1, then
Anillin localization to the equatorial cortex was deemed
‘‘positive.’’
Cell Synchronization, Pull-Downs, and Immunoblotting
HeLa cells and stable cell lines were synchronized as described
[6,12]. Cells were either released from a nocodazole (prometa-
phase) block or forced to exit mitosis by addition of purvalanol A
(Axxora) for 30 min. For all synchronization experiments
involving RNAi, siRNA transfections took place approximately
1 h following release from the first overnight thymidine block so
that the duration of RNAi was between 28 and 32 h. Lysates were
prepared as described [6]. For the Ect2-BRCT and PBD
precipitation experiments, approximately 650 mg of total protein
was incubated with 10 mg of immobilized chitin-binding domain
(CBD)–Ect2-BRCT (1–421) and 10 mg GST–PBD
+ (construct
generously provided by D. Lim and M. Yaffe, Massachusetts
Institute of Technology [MIT]), respectively, for 12–15 h at 4uC
with mixing. For immunoprecipitation experiments, approximate-
ly 1.5–2 mg of total protein was incubated with either 2 mg of anti-
Plk1 or anti-Ect2 antibodies for 12–15 h at 4uC with mixing.
Protein A-sepharose was added and mixing at 4uC was continued
for an additional 45 min. All recombinant beads and immuno-
complexes were washed extensively in lysis buffer and boiled in
sample buffer prior to separation on SDS-PAGE. The following
antibodies were used for Western blot analysis: mouse anti-HsCyk-
4 (Abnova RacGAP1 1:1,000), mouse anti-a-tubulin (Sigma
DM1a 1:10,000), mouse anti-Plk1 (Santa Cruz 1:500), mouse
anti-c-Myc (Boehringer Mannheim 9E10 1:5,000), rabbit anti-
GFP (Santa Cruz 1:500), rabbit anti-Ect2 ([6] 1:1,000), rabbit anti-
Mklp1 ([4] 1:1,000), rabbit anti-Prc1 (Santa Cruz 1:500), rabbit
anti-cyclin B1 (Santa Cruz 1:500), rabbit anti-phospho-Ser170
(generously provided by P. Jallepalli, MS-KCC, 1:1,000) goat-anti-
mouse IR-680 (Invitrogen 1:5,000), and goat-anti-rabbit IR-800
(Jackson Labs 1:5,000). Membranes were imaged using an
Odyssey scanner (Li-Cor) and bands quantified using Odyssey
v2.1 software (Li-Cor).
Peptide Array Analysis
One hundred forty-two 18-mer peptides corresponding to
HsCyk-4 amino acids 1–300 and a positive control Plk1 substrate
peptide (SFNDTLDFD) [44] were synthesized and spotted on
cellulose membranes. The sequence of each 18-mer peptide is
shifted by two residues resulting in a 16 amino acid sequence
overlap. Membranes were equilibrated in kinase buffer (50 mM
Tris-HCl [pH 7.5], 10 mM MgCl2, 1 mM EGTA, and 2 mM
DTT) and incubated with 100 nM full-length recombinant Plk1
T210D or Plk1 K82M/T210D in kinase buffer with 1 mM ATP
and 25 mCi [c-
32P] ATP at 30uC for 60 min. Reaction was
terminated with 100 mM phosphoric acid, and membranes were
washed extensively in 1 M NaCl and 0.5% phosphoric acid.
Membranes were soaked into methanol before drying, then
exposed to phosphor screen (GE Healthcare). The incorporation
of
32P was analyzed by phosphor imager (Typhoon, GE
Healthcare), and spot signal intensities were quantified using
ImageQuant (GE Healthcare).
In Vitro Binding
50 nM of purified recombinant Plk1-T210D 1–306 (generously
provided by D. Lim and M. Yaffe, MIT) was used to
phosphorylate 100 nM bead-bound CBD tagged HsCyk-4-Nt or
Ect2-BRCT in kinase buffer (50 mM Tris-HCl [pH 7.5], 10 mM
MgCl2, 1 mM EGTA, and 2 mM DTT) for 60 min at 30uC with
rigorous mixing. Beads were washed extensively in binding buffer
(20 mM HEPES [pH 7.2], 150 mM NaCl, 5 mM MgCl2,1m M
DTT, 0.1% Triton X-100), and the appropriate binding partner
was added in soluble form at equimolar amounts. Binding
reactions were incubated for 90 min at 4uC with mixing. Beads
were washed extensively in binding buffer and boiled in sample
buffer prior to separation on SDS-PAGE. Bands were visualized
either by Coomassie staining or by Western blot analysis.
Recombinant Protein Expression and Purification
Ect2-BRCT (1–421) and HsCyk-4-Nt (1–288) and associated
derivatives were fused to the CBD and expressed in BL21 (DE3)
RIL cells. Expression was induced by the addition of 0.4 mM
IPTG at 25uC for 4–5 h. Bacteria were resuspended in 10 mM
HEPES (pH 7.7), 250 mM NaCl, 1 mM EGTA, 1 mM MgCl2,
0.1% Triton-X 100, 1 mM DTT, 0.1 mM ATP, 10 mg/ml
leupeptin/pepstatin, and 1 mM phenylmethylsufonylflouride con-
taining 0.5 mg/ml lysozyme prior to sonication. Lysates were
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rotor. Prewashed chitin beads (New England Biolabs) were added
to the cleared lysates and incubated for 2 h at 4uC with mixing.
Following washes, CBD fusions were either maintained on beads,
aliquoted, and stored at 280uC, or the fusion tag was removed by
addition of recombinant Tobacco Etch Virus (TEV) overnight at
4uC with mixing, and the resulting eluate was stored in aliquots at
280uC.
Mutations Thr210 to Asp and Lys82 to Met were introduced in
the cDNA of human Plk1 using site-directed mutagenesis
(Quickchange II, Stratagene) to generate full-length activated
(kinase active [KA]) Plk1 (T210D) and enzymatically inactive
(kinase dead [KD]) Plk1 (K82M/T210D). The resulting Plk1
variants were cloned into pFastBac1 (Invitrogen) containing GST
and a PreScission protease recognition sequence upstream of the
cloning site. GST-Plk1 T210D and GST-Plk1 K82M/T210D
were expressed in Sf-9 cells using the baculovirus system. Infected
cells were incubated for 72 h, treated with 0.1 mM okadaic acid
for 2 h, and then harvested. Cells were resuspended in buffer A
(50 mM HEPES [pH 7.5], 150 mM NaCl, 1 mM EDTA,
2.5 mM EGTA, 0.1% NP-40, 10% glycerol, 1 mM DTT, 1 mM
microcystin LR, and protease inhibitor cocktail [Roche]). After
incubation in buffer A for 30 min at 4uC, cells were lysed by
sonication. Lysates were centrifuged at 28,000g for 30 min at 4uC.
GST fusion proteins purified using glutathione sepharose 4B (GE
Healthcare). GST-Plk1 proteins were eluted in buffer containing
20 mM glutathione and subsequently incubated with PreScission
protease (GE Healthcare) for 3 h at 4uC. Following cleavage, the
reaction mixture was dialyzed three times against buffer C
(50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1 mM EDTA, 10%
glycerol, and 1 mM DTT). To remove GST and PreScission
protease, the dialyzed fraction was incubated with glutathione
sepharose 4B. The flow-through containing Plk1 was frozen in
liquid nitrogen and stored at 280uC. Amount, purity, and activity
of Plk1 T210D and Plk1 K82M/T210D were determined by
SDS-PAGE, Coomassie brilliant blue staining, and in vitro kinase
assays using casein as a model substrate (unpublished data).
Plk1 Kinase Reactions
For labeled kinase reactions, GST and a series of HsCyk-4
fragments fused to the C terminus of GST were expressed in E. coli
and purified using glutathione sepharose 4B (GE Healthcare).
Immobilized GST or GST-HsCyk-4 protein was incubated with
full-length recombinant Plk1 T210D or Plk1 K82M/T210D in
kinase buffer with 50 mM ATP and 1 mCi [c-
32P] ATP at 30uC for
30 min. Beads were washed in PBS containing 1% Triton X-100
and boiled in SDS sample buffer. Samples were resolved by SDS-
PAGE, visualized by Coomassie brilliant blue staining, and finally
analyzed using a phosphor imager (typhoon, GE Healthcare).
Yeast Two Hybrid Analysis
S. cerevisiae strain PJ69-4A (generously provided by K. Gould,
Vanderbilt) was cotransformed by lithium acetate method with
bait (pGBT9, Trp
+) and prey (pGAD424, Leu
+) plasmids
according to standard techniques [45]. Leu
+/Trp
+ transformants
were scored for positive interactions by serial dilution on synthetic
dextrose medium lacking adenine and histidine.
Supporting Information
Figure S1 Plk1 phosphorylates the N terminus of
HsCyk-4 to simulate association with Ect2-BRCT. (A)
Schematic of experimental design (upper diagram; same as
Figure 2A). Recombinant HsCyk-4-Nt or Ect2-BRCT fused to
CBD was incubated in the presence (+) or absence (2) of Plk1-
T210 kinase domain and ATP. Soluble HsCyk-4-Nt or Ect2-
BRCT was added to the washed beads, mixed, and then separated
on SDS-PAGE and probed with antibodies to Ect2 and HsCyk-4
(lower gels). Input represents 50% of the total soluble protein
incubated with immobilized protein. (B) Recombinant HsCyk-4-
Nt and indicated derivatives fused to CBD were assayed for Plk1
phosphorylation and Ect2-BRCT binding as in (A). Proteins were
resolved on SDS-PAGE and Coomassie stained for visualization.
Input represents 50% of the total soluble protein incubated with
immobilized protein.
Found at: doi:10.1371/journal.pbio.1000110.s001 (2.87 MB EPS)
Figure S2 Plk1 phosphorylates N-terminal peptides of
HsCyk-4 on four serine residues. (A) Synthesized 18-mer
peptides, corresponding to HsCyk-4 1–300, and control peptide
were spotted on cellulose membranes. Membranes were incubated
with full-length recombinant Plk1 T210D (upper panel) or Plk1
K82M/T210D (middle panel) and [c-
32P] ATP. Incorporation of
32P was visualized by autoradiography. (B) Immobilized GST,
GST-HsCyk-4 (111–188), and GST-HsCyk-4 4A (111–188) were
incubated with recombinant Plk1 T210D (KA) or Plk1 K82M/
T210D (KD) and [c-
32P] ATP. Proteins were separated by SDS-
PAGE and visualized by Coomassie brilliant blue staining.
Incorporation of
32P was analyzed by autoradiography. Relative
incorporation of
32P to GST-HsCyk-4 was quantified and is shown
below the corresponding lanes.
Found at: doi:10.1371/journal.pbio.1000110.s002 (6.79 MB EPS)
Figure S3 Association of HsCyk-4-Nt and Ect2-BRCT in
yeast. Strain KGY 1296 was cotransformed with the indicated
bait (pGBT9) and prey (pGAD424) plasmids and selected on
media lacking Trp and Leu. Cotransformed cells were serially
diluted (1:10) onto either +His +Ade medium (growth does not
require reporter activation) or 2His 2Ade (growth requires
reporter activation). EV, empty vector control.
Found at: doi:10.1371/journal.pbio.1000110.s003 (3.43 MB EPS)
Figure S4 Characterization of cell lines stably express-
ing HsCyk-4–EGFP derivatives. (A) The indicated stable cell
lines transfected with siRNA to deplete endogenous HsCyk-4 were
synchronized in anaphase using a MG132 arrest/release protocol.
Cells were fixed and stained with GFP antibodies and 49,6-
diamidino-2-phenylindole (DAPI), and scored for percentage of
anaphase cells possessing HsCyk-4–EGFP at the central spindle
(n=100). (B) The indicated stable cell lines were transfected with
siRNA to deplete endogenous HsCyk-4 and synchronized in
anaphase using a MG132 arrest/release protocol. Cells were fixed
and stained with antibodies to GFP and Prc1, and DNA was
stained with DAPI. (C) The indicated stable cell lines were either
mock transfected (control) or transfected with siRNA to deplete
endogenous HsCyk-4 and synchronized in anaphase using a
MG132 arrest/release protocol. Cells were fixed and stained with
antibodies to GFP and phospho-Ser170, and DNA was stained
with DAPI. (D) Relative amounts of endogenous HsCyk-4 levels
were determined in mock-transfected cells (control) and in cells
transfected with siRNA to deplete endogenous HsCyk-4 for
between 28 and 32 h. Lysates were prepared, separated on SDS-
PAGE, and probed with antibodies to HsCyk-4 and a-tubulin as a
loading control. Quantification of band intensities was performed
using Odyssey v2.1 software. Standard deviation was generated
from at least four independent experiments.
Found at: doi:10.1371/journal.pbio.1000110.s004 (7.04 MB EPS)
Figure S5 Transiently transfected HsCyk-4-4A–EGFP
fails to promote cleavage furrow formation and
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indicated HsCyk-4–EGFP fusions and siRNAs to deplete endog-
enous HsCyk-4 were filmed by live video microscopy and scored
for cytokinesis failure as in Figure 3C. The total number of
transfected cells scored for each cell line: EGFP, n=13; wt, n=12;
4A, n=17; 4D, n=12. (B) HeLa cells cotransfected with the
indicated HsCyk-4-EGFP fusions and siRNAs to deplete endog-
enous HsCyk-4 were synchronized in prometaphase with
nocodazole and released by addition of 22.5 mM purvalanol A.
Lysates were prepared, precipitated with recombinant Ect2-
BRCT, washed and separated on SDS-PAGE, and probed with
antibodies to HsCyk-4 and a-tubulin. Lysates represent approx-
imately 5% of input.
Found at: doi:10.1371/journal.pbio.1000110.s005 (1.69 MB EPS)
Figure S6 Determination of Ect2 and Anillin failure to
localize to the central spindle and equatorial cortex,
respectively, in HsCyk-4-4A–EGFP–expressing cells. (A)
The indicated stable HeLa cell lines expressing HsCyk-4–EGFP
were transfected with siRNAs to deplete endogenous HsCyk-4 and
synchronized in anaphase using a MG132 arrest/release protocol.
Cells were fixed and stained with Ect2 and GFP antibodies, and
DNA was visualized using DAPI. Positive central spindle
accumulation of Ect2 was determined as indicated in Materials
and Methods. (B) A subset of the cells analyzed in Figure 4A were
selected for quantification, and the intensity of Ect2 at the central
spindle (quantified as above) was plotted relative to HsCyk-4–
EGFP levels for the indicated stable cell lines depleted for
endogenous HsCyk-4. The area above the dashed line represents
those cells possessing ‘‘positive’’ Ect2 central spindle localization;
below the dashed line represents ‘‘failed’’ central spindle
localization. (C) The indicated stable cell lines transfected with
siRNA to deplete endogenous HsCyk-4 were synchronized in
anaphase using an MG132 arrest/release protocol. Cells were
fixed and stained with antibodies to GFP and Anillin, and DNA
was stained with DAPI. Percentage of cells with positive Anillin
localization (see Materials and Methods section for assessment of
‘‘positive’’) to the equatorial cortex was determined in at least 100
cells. (D) A subset of the cells analyzed in Figure S6C were chosen
for quantification, and the ratio of fluorescence intensity values of
Anillin at the equatorial cortex: Anillin in the cytoplasm
(quantified as above) was plotted relative to HsCyk-4–EGFP levels
for the indicated stable cell lines depleted for endogenous HsCyk-
4. The area above the dashed line represents those cells possessing
‘‘positive’’ Anillin localization to the equatorial cortex; below the
dashed line represents ‘‘failed’’ cortical localization.
Found at: doi:10.1371/journal.pbio.1000110.s006 (6.26 MB EPS)
Figure S7 Plk1 associates with Prc1, but not HsCyk-4,
during forced mitotic exit. (A) HeLa cells synchronized with
nocodazole were treated with DMSO or 22.5 mM purvalanol A in
the presence or absence of 100 nM BI-2536. Lysates and Plk1
immunoprecipitates were separated on SDS-PAGE and probed
with Plk1, Prc1, Ect2, and HsCyk-4 antibodies. (B) HeLa cells
synchronized with nocodazole were treated with either DMSO,
22.5 mM purvalanol A, or 100 nM BI-2536. Lysates and PBD-
bound (PBD
+) fractions were separated on SDS-PAGE and
probed with Ect2, Prc1, and HsCyk-4 antibodies (upper panels).
Lysate represents approximately 5% of input. The ratio of PBD
bound HsCyk-4, Ect2, and Prc1 in purvalanol A or BI-2536
treated cells over nocodazole control were plotted (lower panel).
Found at: doi:10.1371/journal.pbio.1000110.s007 (4.58 MB EPS)
Figure S8 HsCyk-4 remains phosphorylated on Ser-170
in cells expressing Prc1-ST601/2AA. (A) HeLa cells
cotransfected with siRNA to deplete endogenous Prc1 and
CMV-Myc-Prc1-wt (wt) or CMV-Myc-Prc1-ST601/2AA (AA)
were synchronized in anaphase using an MG132 arrest/release
protocol. Cells were fixed and stained with antibodies to Myc and
Plk1, and DNA was stained with DAPI. (B) HeLa cells
cotransfected with siRNA to deplete endogenous Prc1 and the
indicated CMV-Myc-Prc1 constructs were arrested in prometa-
phase with nocodazole. Cells were released with addition of
22.5 mM purvalanol A for 30 min. Lysates were prepared,
immunoprecipitated using Plk1 antibodies, washed, and separated
on SDS-PAGE. Blots were probed with antibodies to Myc and
Plk1. Asterisks indicate the position of cross-reacting species
recognized by Myc antibodies. Lysate represents approximately
5% of the input. (C) HeLa cells transfected and synchronized as in
(A) were fixed and stained with antibodies to Myc and phospho-
170, and DNA was stained with DAPI.
Found at: doi:10.1371/journal.pbio.1000110.s008 (8.42 MB EPS)
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